Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma or Other Advanced Solid Malignancies

NCT01665183 is registered in ClinicalTrials.gov with Polaris Group as lead sponsor.

NCT NCT01665183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01665183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma or Other Advanced Solid Malignancies
Lead sponsor
Polaris Group
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2012
Completion date
February 29, 2016
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma, uveal melanoma, ovarian carcinoma or other advanced solid tumors